StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioLargo's price to sales ratio was 5.6× on Oct 19, 2026, against 3.4× a year earlier. Over the last 5 years it ranged from 3.0× to 24.5×, with a median of 6.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20265.6×+0.4
2025Dec 31, 20255.2×+2.1
2024Dec 31, 20243.0×−1.8
2023Dec 29, 20234.8×−6.1
2022Dec 30, 202211.0×−8.1
2021Dec 31, 202119.1×+8.5
2020Dec 31, 202010.5×−6.9
2019Dec 31, 201917.5×−6.0
2018Dec 31, 201823.5×−74.1
2017Dec 29, 201797.6×−168.3
2016Dec 30, 2016265.9×−36.8
2015Dec 31, 2015302.7×−140.8
2014Dec 31, 2014443.5×+159.4
2013Dec 31, 2013284.1×+53.7
2012Dec 31, 2012230.4×+104.0
2011Dec 30, 2011126.5×–

More BioLargo figures

See a number that looks wrong?